Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation
Authors
Keywords
Methotrexate, Osteosarcoma, Epigenetic regulation, DNA methylation, Histone acetylation, All-<em class=EmphasisTypeItalic >trans</em> retinoic acid, Osteogenic differentiation
Journal
Cancer Cell International
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-29
DOI
10.1186/s12935-016-0289-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in emerging drugs for osteosarcoma
- (2015) Claudia Maria Hattinger et al. EXPERT OPINION ON EMERGING DRUGS
- Solid Tumor Differentiation Therapy – Is It Possible?
- (2015) Filemon Dela cruz et al. Oncotarget
- E2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα
- (2014) Lei Zhang et al. CELL CYCLE
- Relationship between RFC gene expression and intracellular drug concentration in methotrexate-resistant osteosarcoma cells
- (2014) J.J. Wang et al. GENETICS AND MOLECULAR RESEARCH
- LOX/COX inhibitors enhance the antineoplastic effects of all-trans retinoic acid in osteosarcoma cell lines
- (2014) Miroslava Krzyzankova et al. TUMOR BIOLOGY
- Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia
- (2013) Akihiro Tomita et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Methotrexate-Induced Decrease in Embryonic 5-Methyl-Tetrahydrofolate Is Irreversible with Leucovorin Supplementation
- (2013) Tseng-Ting Kao et al. Zebrafish
- Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate's Role
- (2012) Krista S. Crider et al. Advances in Nutrition
- Reduction of Fas/CD95 Promoter Methylation, Upregulation of Fas Protein, and Enhancement of Sensitivity to Apoptosis in Cutaneous T-Cell Lymphoma
- (2010) Jianqiang Wu et al. ARCHIVES OF DERMATOLOGY
- The sequence of application of methotrexate and histone deacetylase inhibitors determines either a synergistic or an antagonistic response in childhood acute lymphoblastic leukemia cells
- (2010) L Bastian et al. LEUKEMIA
- Inhibition of histone deacetylase activity is a novel function of the antifolate drug methotrexate
- (2009) Pei-Ming Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High-dose Methotrexate in Pediatric Oncology—Back to Bench From Bedside for a While?
- (2009) Jaroslav Sterba et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences
- (2009) S. J. Diede et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines
- (2008) Renata Veselska et al. BMC CANCER
- High-Dose Methotrexate in Osteosarcoma: Let the Questions Surcease—Time for Final Acceptance
- (2008) Norman Jaffe et al. JOURNAL OF CLINICAL ONCOLOGY
- Retinoic acid syndrome: a review
- (2008) E. Patatanian et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells
- (2008) Alan Kambiz Fotoohi et al. LEUKEMIA & LYMPHOMA
- Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity
- (2008) Sandra Vezmar et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation